NO975318L - Hemodilusjon, lettet ved overvåking av oksygeneringsstatus - Google Patents

Hemodilusjon, lettet ved overvåking av oksygeneringsstatus

Info

Publication number
NO975318L
NO975318L NO975318A NO975318A NO975318L NO 975318 L NO975318 L NO 975318L NO 975318 A NO975318 A NO 975318A NO 975318 A NO975318 A NO 975318A NO 975318 L NO975318 L NO 975318L
Authority
NO
Norway
Prior art keywords
hemodilution
facilitated
oxygenation status
monitoring oxygenation
monitoring
Prior art date
Application number
NO975318A
Other languages
English (en)
Norwegian (no)
Other versions
NO975318D0 (no
Inventor
Nicolas Simon Faithfull
Peter E Keipert
Duane J Roth
Ronald M Hopkins
Original Assignee
Alliance Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alliance Pharma filed Critical Alliance Pharma
Publication of NO975318D0 publication Critical patent/NO975318D0/no
Publication of NO975318L publication Critical patent/NO975318L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/41—Porphyrin- or corrin-ring-containing peptides
    • A61K38/42—Haemoglobins; Myoglobins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/02—Halogenated hydrocarbons
    • A61K31/025—Halogenated hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/02—Halogenated hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • External Artificial Organs (AREA)
NO975318A 1995-06-07 1997-11-19 Hemodilusjon, lettet ved overvåking av oksygeneringsstatus NO975318L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/484,166 US5865784A (en) 1995-06-07 1995-06-07 Method of hemodilution facilitated by monitoring oxygenation status
PCT/US1996/009990 WO1996040222A1 (en) 1995-06-07 1996-06-07 Hemodilution facilitated by monitoring oxygenation status

Publications (2)

Publication Number Publication Date
NO975318D0 NO975318D0 (no) 1997-11-19
NO975318L true NO975318L (no) 1998-01-30

Family

ID=23923030

Family Applications (1)

Application Number Title Priority Date Filing Date
NO975318A NO975318L (no) 1995-06-07 1997-11-19 Hemodilusjon, lettet ved overvåking av oksygeneringsstatus

Country Status (13)

Country Link
US (3) US5865784A (zh)
EP (1) EP0831890A1 (zh)
JP (1) JPH11507378A (zh)
KR (1) KR19990022355A (zh)
CN (2) CN1192155A (zh)
AU (1) AU717317B2 (zh)
CA (1) CA2222066A1 (zh)
HU (1) HUP9802266A3 (zh)
IL (1) IL122239A0 (zh)
NO (1) NO975318L (zh)
PL (1) PL323937A1 (zh)
WO (1) WO1996040222A1 (zh)
ZA (1) ZA964656B (zh)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6676900B1 (en) 1994-12-09 2004-01-13 Therox, Inc. Method for the preparation and delivery of gas-enriched fluids
US6180059B1 (en) * 1995-06-05 2001-01-30 Therox, Inc. Method for the preparation and delivery of gas-enriched fluids
US5865784A (en) 1995-06-07 1999-02-02 Alliance Pharmaceutical Corp. Method of hemodilution facilitated by monitoring oxygenation status
AU747878B2 (en) * 1998-04-09 2002-05-30 California Institute Of Technology Electronic techniques for analyte detection
GB2343679A (en) * 1998-11-16 2000-05-17 Alison Miriam Davies Autologous transplantation and method for making cells dormant
US6582386B2 (en) 2001-03-06 2003-06-24 Baxter International Inc. Multi-purpose, automated blood and fluid processing systems and methods
US6706008B2 (en) 2001-03-06 2004-03-16 Baxter International Inc. Automated system and method for withdrawing compounds from blood
US6808503B2 (en) 2001-03-06 2004-10-26 Baxter International Inc. Automated system and method for pre-surgical blood donation and fluid replacement
US6884228B2 (en) 2001-03-06 2005-04-26 Baxter International Inc. Automated system adaptable for use with different fluid circuits
US6811778B2 (en) 2001-09-10 2004-11-02 Biopure Corporation Method for improving oxygen transport by stored red blood cells
DE60229416D1 (de) 2001-10-25 2008-11-27 Univ Emory Katheter für modifizierte Perfusion
US20070160645A1 (en) * 2001-10-25 2007-07-12 Jakob Vinten-Johansen PostConditioning System And Method For The Reduction Of Ischemic-Reperfusion Injury In The Heart And Other Organs
WO2004064622A2 (en) * 2003-01-15 2004-08-05 Medcool Inc. Method and apparatus for managing temperature in a patient
JP4773098B2 (ja) * 2003-01-23 2011-09-14 ユニバーシティ オブ フロリダ リサーチ ファンデーション インコーポレーティッド 呼気を用いる静脈薬剤濃度をモニタするための方法および装置
AU2007267997A1 (en) * 2006-05-22 2007-12-06 Alliance Pharmaceutical Corp. Optimized fluorocarbon emulsions for blood substitutes and other therapeutic uses
US20100093873A1 (en) * 2008-10-02 2010-04-15 Goldfischer Sidney L Methods of improving therapy of perfluorocarbons (PFC)
US20100143192A1 (en) * 2008-12-04 2010-06-10 Therox, Inc. Method and device for combined detection of bubbles and flow rate in a system for enriching a bodily fluid with a gas
US8246564B2 (en) * 2008-12-04 2012-08-21 Therox, Inc. System for enriching a bodily fluid with a gas having automated priming capabilities
US8636952B2 (en) * 2008-12-04 2014-01-28 Therox, Inc. System for enriching a bodily fluid with a gas having a removable gas-enrichment device with an information recording element
US20100143190A1 (en) * 2008-12-04 2010-06-10 Therox, Inc. System for enriching a bodily fluid with a gas having occlusion detection capabilities
US8192384B2 (en) * 2008-12-04 2012-06-05 Therox, Inc. System for enriching a bodily fluid with a gas having a dual-function power switch mechanism
US7989593B1 (en) 2010-05-27 2011-08-02 Bing Lou Wong Method for the preparation of a high-temperature stable oxygen-carrier-containing pharmaceutical composition and the use thereof
US8048856B1 (en) 2010-06-23 2011-11-01 Billion King, Ltd. Treatment methods using a heat stable oxygen carrier-containing pharmaceutical composition
US7932356B1 (en) 2010-06-23 2011-04-26 Bing Lou Wong Method for the preparation of a heat stable oxygen carrier-containing pharmaceutical composition
US8084581B1 (en) 2011-04-29 2011-12-27 Bing Lou Wong Method for removing unmodified hemoglobin from cross-linked hemoglobin solutions including polymeric hemoglobin with a high temperature short time heat treatment apparatus
US20130052232A1 (en) 2011-08-31 2013-02-28 Bing Lou Wong Method for the preparation of a heat stable oxygen carrier-containing composition facilating beta-beta cross-linking
CN108380965B (zh) * 2013-04-04 2021-02-19 米沃奇电动工具公司 电动工具
GB2540724A (en) * 2015-03-06 2017-02-01 Spectrum Medical Ltd Blood analysis apparatus and method

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3482575A (en) 1967-02-16 1969-12-09 Single Cell Research Foundatio Method for the extracorporeal oxygenation of blood
US3958014A (en) 1970-09-05 1976-05-18 The Green Cross Corporation Process for preparing injection-purpose fluorocarbon emulsion capable of carrying oxygen
US3975512A (en) * 1970-12-21 1976-08-17 University Of Illinois Foundation Non-toxic brominated perfluorocarbons radiopaque agents
US4073879A (en) * 1974-08-26 1978-02-14 University Of Illinois Foundation Brominated perfluorocarbon radiopaque agents
DE2754894C2 (de) 1977-12-09 1983-10-13 Fresenius AG, 6380 Bad Homburg Vorrichtung zum Bilanzieren einer einem Patienten entnommenen Flüssigkeit mit einer Ersatzflüssigkeit
EP0031353B1 (en) 1979-06-25 1984-08-08 Suntech, Inc. Use of perfluorocarbon as burn treatment
JPS6023084B2 (ja) * 1979-07-11 1985-06-05 味の素株式会社 代用血液
US4657532A (en) 1985-07-19 1987-04-14 Thomas Jefferson University Intra-peritoneal perfusion of oxygenated fluorocarbon
US4981691A (en) 1980-04-14 1991-01-01 Thomas Jefferson University Oxygenated fluorocarbon nutrient solution
FR2515198A1 (fr) 1981-10-22 1983-04-29 Centre Nat Rech Scient Microemulsions aqueuses de fluorocarbures indefiniment stables a une temperature donnee, procede d'obtention et application a titre de transporteurs d'oxygene
JPS5832829A (ja) 1981-08-22 1983-02-25 Green Cross Corp:The 血管造影剤
DE3144705C2 (de) * 1981-11-11 1983-12-08 Biotest-Serum-Institut Gmbh, 6000 Frankfurt Verfahren zur Herstellung eines lagerstabilen, vernetzten Hämoglobinpräparates mit hoher Sauerstoff-Transportkapazität, sowie das nach diesem Verfahren hergestellte Hämoglobinpräparat
US4425334A (en) 1982-04-02 1984-01-10 The Regents Of The University Of California Functional oxygen transport system
US4473494A (en) * 1983-05-04 1984-09-25 The United States Of America As Represented By The Secretary Of The Army Preparation of stroma-free, non-heme protein-free hemoglobin
DE3340592A1 (de) * 1983-11-10 1985-05-23 B. Braun Melsungen Ag, 3508 Melsungen Konjugate makromolekularer verbindungen an haemoglobine, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
JPS60166626A (ja) 1984-02-09 1985-08-29 Green Cross Corp:The 血管造影剤
DE3412144A1 (de) * 1984-03-31 1985-10-10 Biotest Pharma GmbH, 6000 Frankfurt Verfahren zur herstellung hochgereinigter, stromafreier, hepatitissicherer human- und tierhaemoglobinloesungen
US4600531A (en) * 1984-06-27 1986-07-15 University Of Iowa Research Foundation Production of alpha-alpha cross-linked hemoglobins in high yield
US4987154A (en) * 1986-01-14 1991-01-22 Alliance Pharmaceutical Corp. Biocompatible, stable and concentrated fluorocarbon emulsions for contrast enhancement and oxygen transport in internal animal use
US5080885A (en) 1986-01-14 1992-01-14 Alliance Pharmaceutical Corp. Brominated perfluorocarbon emulsions for internal animal use for contrast enhancement and oxygen transport
US4927623A (en) 1986-01-14 1990-05-22 Alliance Pharmaceutical Corp. Dissolution of gas in a fluorocarbon liquid
US4865836A (en) * 1986-01-14 1989-09-12 Fluoromed Pharmaceutical, Inc. Brominated perfluorocarbon emulsions for internal animal use for contrast enhancement and oxygen transport
US4911929A (en) * 1986-08-29 1990-03-27 The United States Of America As Represented By The Secretary Of The Navy Blood substitute comprising liposome-encapsulated hemoglobin
US4861667A (en) 1986-12-19 1989-08-29 Asahi Glass Company, Ltd. Coating composition and coated product
GB8710598D0 (en) * 1987-05-05 1987-06-10 Star Medical Diagnostics Ltd Hemoglobin based blood substitute
US4861867A (en) * 1988-02-03 1989-08-29 Baxter International, Inc. Purified hemoglobin solutions and method for making same
US5130230A (en) 1988-05-02 1992-07-14 Cryomedical Sciences, Inc. Blood substitute
US4911999A (en) 1988-12-13 1990-03-27 E. I. Du Pont De Nemours And Company Electrostatic master containing thiourea or thioamide electrostatic decay additive for high speed xeroprinting
US5344393A (en) 1992-02-28 1994-09-06 Alliance Pharmaceutical Corp. Use of synthetic oxygen carriers to facilitate oxygen delivery
US5865784A (en) 1995-06-07 1999-02-02 Alliance Pharmaceutical Corp. Method of hemodilution facilitated by monitoring oxygenation status

Also Published As

Publication number Publication date
CN1720904A (zh) 2006-01-18
AU717317B2 (en) 2000-03-23
NO975318D0 (no) 1997-11-19
ZA964656B (en) 1997-02-28
CA2222066A1 (en) 1996-12-19
KR19990022355A (ko) 1999-03-25
US5865784A (en) 1999-02-02
EP0831890A1 (en) 1998-04-01
JPH11507378A (ja) 1999-06-29
US6007774A (en) 1999-12-28
WO1996040222A1 (en) 1996-12-19
CN1192155A (zh) 1998-09-02
IL122239A0 (en) 1998-04-05
USRE38081E1 (en) 2003-04-15
HUP9802266A3 (en) 2001-03-28
PL323937A1 (en) 1998-04-27
HUP9802266A2 (hu) 1999-02-01
AU6271396A (en) 1996-12-30

Similar Documents

Publication Publication Date Title
NO975318L (no) Hemodilusjon, lettet ved overvåking av oksygeneringsstatus
TR199600096A2 (tr) Yeni bilesikler.
DE69515586T2 (de) Sauerstoffdurchlässige, zusammengesetzte, leitende Membranen
TR199600024A2 (tr) Yeni pestisitler.
DZ1961A1 (fr) Nouveaux composés.
BR9602933B1 (pt) compostos dihidrodibenzo [b,f] azepinas substituÍdas.
TR199501597A2 (tr) Yeni bilesikler.
NO963955D0 (no) Manipuleringsikkert, barnebestandig lukke
FI950715A0 (fi) Ytmikromekanisk, symmetrisk tryckskillnadsgivare
DE59507222D1 (de) Substituierte 1,2,3,4-tetrahydro-5-nitro-pyrimidine
BR9609884A (pt) N-aril- 1,2,4-triazolin-5-onas
DE69618634D1 (de) 1,4-benzodioxin-derivate
NO960499L (no) Antineurodegenerativt virksomme 10-aminoalifatyldibenz[b,fÅoksepiner
TR199801463A3 (tr) Koruyucu kolloid olarak yeni kolloid dispersiyon karisimlari.
TR199600778A2 (tr) Yeni sülfonamidler.
DK0874814T3 (da) 25-hydroxy-16-en-26,27-bishomo-cholecalciferoler
ID19571A (id) Proses pemurnian 1,4-butanadiol mentah
TR199501320A2 (tr) Anti- aritmik maddeler olarak faydali yeni bilesikler.
TR199600889A2 (tr) Fungisit bilesikler (B).
FR2720395B1 (fr) Nouveaux composés de la famille des benzohétérocycles.
TR199500781A2 (tr) Yeni bilesik.
IT1280417B1 (it) Composti a struttura 3,4 diidro-2-iodometil-2,5,7,8-tetrametil-2h-1 benzopiranica.
FI943203A0 (fi) Apparatur foer spridning av flytande aemne, saerskilt foer spridning av utrotningsmedel foer ograesvaexten
TR199600141A2 (tr) Yeni retinoidler.
BR9610047A (pt) 1,3,4-oxadiazolin-2-onas